Map Unavailable

Date/Time
Date(s) - 24/06/2020
1:00 am - 5:00 am


Now in its third year hosted by Roche in Basel, the Digital Biomarkers in Clinical Trials Summit is the first and only global forum of its kind to focus on ways for pharma clinical trials to take advantage of new opportunities to collect better data and improve the patient experience; as well as how these new digital health tools supplement existing biomarker strategies.

Join 15+ speakers, 300+ senior-level pharma, clinical trials, technology and digital health executives virtually on June 24th, 2020 at Roche in Basel to learn, network, develop and improve the way pharma clinical trials utilize mobile-enabled, wearables, and IoT capabilities to improve existing biomarker strategies, improve patient experience and collect better data.

Global experts converge at the forefront of wearable sensor technology, data management, analytics, connected device & biomarkers strategies in clinical trials. If you’re involved with R&D, sales & marketing, information technology, data management, patient recruitment, retention, adherence, digital health, digital biomarkers, quantitative or translational medicine – this is the place to be.

ARE DIGITAL BIOMARKERS READY FOR AN AAAA RATING?
OVERALL THEMES:1. The State of Digital Biomarkers Today

2. Best Practices for Digital Protocol ADHERENCE

3. How Can the Industry Come to AGREEMENT between Classical Physician Assessments and the new Digital Measures?

4. Where Can the Industry Collaborate on AUGMENTATION?

5. How Can Life Sciences work with Regulatory AUTHORITIES to Accelerate Adoption?

 

Link Event: http://digitalbiomarkers.panagorapharma.com/

Organized in partnership with ROCHE.